Single cell CNV and ATAC profiling of multiple myeloma
Patient-derived samples were profiled using 10X genomics single-cell CNV and single-cell ATAC kits.
- 10 samples
- DAC: EGAC00001002170
- Technologies: Illumina NovaSeq 6000, NextSeq 500
Requests to access the data should follow the guidance as outlined in the policy agreement below. Requests are to be submitted to members of the data access committee, including a brief description of the research project (complete Appendix II in the policy section below) and approval by the requestor institution. All requests will be reviewed by the members of the data access committee as well as the Governors of the University of Calgary
DATA ACCESS AGREEMENT BETWEEN THE GOVERNORS OF THE UNIVERSITY OF CALGARY 2500 University Drive NW Calgary, Alberta T2N 1N4 Canada (“UCalgary”) and OTHER PARTY These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom UCalgary grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: UCalgary and the collaborators listed in Appendix I responsible for the development, organization, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research but does not include commercial purposes. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorized Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documen ts/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognizing the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution shall be entitled to publish the results of the Project. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees that it will consult with UCalgary in respect to licensing of any downstream discovery to ensure that UCalgary is not in breach of any third-party commitments that UCalgary has made in respect of the data. 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify UCalgary within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify UCalgary prior to any significant changes to the protocol for the Project. 14. The User Institution will notify UCalgary as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. UCalgary may terminate this agreement upon thirty (30) days written notice to the User Institution for material breach, which shall only take effect if User Institution either fails or cannot cure the material breach within thirty (30) days of receiving notice. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than UCalgary. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement.
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
Study ID | Study Title | Study Type |
---|---|---|
EGAS00001005382 | Other |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.
ID | File Type | Size | Located in | |
---|---|---|---|---|
EGAF00005319376 | bam | 12.6 GB | ||
EGAF00005319377 | bam | 13.2 GB | ||
EGAF00005319378 | bam | 46.2 GB | ||
EGAF00005319379 | bam | 46.0 GB | ||
EGAF00005319380 | bam | 32.4 GB | ||
EGAF00005319381 | bam | 8.8 GB | ||
EGAF00005319382 | bam | 55.7 GB | ||
EGAF00005319383 | bam | 7.8 GB | ||
EGAF00005319384 | bam | 13.0 GB | ||
EGAF00005319385 | bam | 18.4 GB | ||
EGAF00005321531 | bam | 287.0 GB | ||
EGAF00005321532 | bam | 62.9 GB | ||
EGAF00005321533 | bam | 56.1 GB | ||
EGAF00005321534 | bam | 255.6 GB | ||
EGAF00005321535 | bam | 74.7 GB | ||
EGAF00005321536 | bam | 98.1 GB | ||
EGAF00005321537 | bam | 21.2 GB | ||
EGAF00005321538 | bam | 40.9 GB | ||
EGAF00005321539 | bam | 85.4 GB | ||
EGAF00005321540 | bam | 59.8 GB | ||
20 Files (1.3 TB) |